Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.89)
# 3,241
Out of 5,033 analysts
207
Total ratings
25%
Success rate
-2.73%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.03 | +773.79% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.55 | +1,347.96% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.33 | +256.47% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.11 | +89.57% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $4.30 | -53.49% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.51 | +1,468.63% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.18 | +497.48% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.36 | +790.81% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.72 | +772.09% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $0.54 | +10,209.28% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.76 | +1,217.35% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.41 | +390.20% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.19 | +615.99% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.10 | +134.57% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.44 | +365.12% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.07 | +460.75% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.45 | +6,796.55% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.50 | +3,492.81% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.29 | +773.36% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $6.13 | +256,833.12% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $18.88 | +2,548.31% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $20.23 | +1,086.36% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.55 | +5,061.29% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,500 | $9.54 | +15,631.52% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.69 | +119,570.91% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.20 | +483.33% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.32 | +1,193.10% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.20 | +852.38% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $8.85 | +103.39% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.99 | +0.20% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $4.46 | +32,187.00% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $58.44 | -58.93% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.37 | +249,535.04% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.50 | +1,266,566.67% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.03
Upside: +773.79%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.55
Upside: +1,347.96%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.33
Upside: +256.47%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.11
Upside: +89.57%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $4.30
Upside: -53.49%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.51
Upside: +1,468.63%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.18
Upside: +497.48%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.36
Upside: +790.81%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.72
Upside: +772.09%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $0.54
Upside: +10,209.28%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $0.76
Upside: +1,217.35%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.41
Upside: +390.20%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $4.19
Upside: +615.99%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.10
Upside: +134.57%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.44
Upside: +365.12%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.07
Upside: +460.75%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.45
Upside: +6,796.55%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.50
Upside: +3,492.81%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.29
Upside: +773.36%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $6.13
Upside: +256,833.12%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $18.88
Upside: +2,548.31%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $20.23
Upside: +1,086.36%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.55
Upside: +5,061.29%
Jun 30, 2021
Initiates: Buy
Price Target: $1,500
Current: $9.54
Upside: +15,631.52%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.69
Upside: +119,570.91%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.20
Upside: +483.33%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.32
Upside: +1,193.10%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.20
Upside: +852.38%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $8.85
Upside: +103.39%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $4.99
Upside: +0.20%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $4.46
Upside: +32,187.00%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $58.44
Upside: -58.93%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.37
Upside: +249,535.04%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.50
Upside: +1,266,566.67%